First cannabis-based product under MCAP to be available from next month

First cannabis-based product under MCAP to be available from next month

Epilepsy is one of the main conditions people are seeking cannabis treatment for in Ireland. File photo: iStock

The first cannabis-based product to be made available through the Medical Cannabis Access Programme will be accessible from mid-October.

The product is CannEpil oral solution which contains both tetrahydrocannabinol (THC) a psychoactive derivative of cannabis, and cannabidiol (CBD).

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited